To investigate the relationship between pre-thrombolysis blood pressure and collateral circulation in acute ischemic stroke(AIS) patients and its impact on prognosis.
A total of 191 AIS patients treated with intravenous thrombolysis(IVT) alone in the Department of Neurology, Shanghai Pudong Gongli Hospital from January 2023 to June 2024 were enrolled. Patients were divided into the normal blood pressure group and the elevated blood pressure group based on pre-thrombolysis blood pressure. All patients underwent collateral circulation assessment using multimodal computed tomography angiography+computed tomography perfusion imaging before thrombolysis. Clinical data and 90-day post-thrombolysis outcomes were compared between groups. Logistic regression analysis was performed with whether the prognosis was good as the dependent variable.
Good collateral circulation significantly reduced hemorrhagic transformation risk, extended the therapeutic time window, and improved 90-day functional outcomes(P<0.001). The elevated blood pressure group had a higher prevalence of hypertension(80.2% vs. 63.3%, P=0.013) and prolonged door-to-needle time[(47.92±28.3) min vs. (37.63±16.4) min, P=0.010], but no direct correlation was found between pre-thrombolysis blood pressure and collateral compensation capacity (collateral adequacy rate: 78.3% vs. 69.5%,P=0.204). Patients with poor collaterals exhibited higher rates of atrial fibrillation(P=0.003), advanced age(P=0.011),and severe neurological deficits(P<0.001). Regression analysis showed that good collateral circulation was the strongest predictor of favorable short-term[odds ratio(OR)=3.403, P=0.009] and long-term(OR=23.442, P<0.001) outcomes.Chronic hypertension may inhibit collateral compensation through vascular stiffness and microcirculatory dysfunction,significantly increased the risk of long-term adverse outcomes(OR=0.354, P=0.021).
Prethrombolysis blood pressure cannot reliably predict collateral circulation status. Alberta stroke program early CT score can accurately assess collateral circulation and have a clear guiding therapeutic effect on IVT. Clinical management should balance acute-phase blood pressure control with collateral protection, prioritizing imaging-based collateral evaluation for individualized therapy.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |